Pear Therapeutics, Inc. (PEAR) Stock Analysis
DELISTED 2023
What happened to Pear Therapeutics, Inc. (PEAR) stock?
Pear Therapeutics, Inc. (PEAR) no longer trades on public markets. It was delisted in April 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- April 2023
- Last recorded price (historical):
- $0.0292 (last quote on record before the April 2023 delisting; historical, not a current quote)
Market cap $4.09M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Pear Therapeutics, Inc. (PEAR). Pear Therapeutics, Inc. is a commercial-phase medical company focused on inventing and distributing prescription digital therapeutics (PDTs) for conditions like substance use disorders, opioid use disorder, and chronic insomnia.
Last analyzed: Jun 15, 2026Pear Therapeutics, Inc. (PEAR) Healthcare & Pipeline Overview
More about this archive record
Can I still buy PEAR shares?
No. PEAR stopped trading on public markets in April 2023, so the shares are not available through a broker. Anything you see quoted for PEAR elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before PEAR stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Pear Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.